Published in Z Immunitatsforsch Exp Klin Immunol on May 01, 1974
Microheterogeneity forms of alpha 1-acid glycoprotein as indicators of rheumatoid arthritis activity. Clin Chim Acta (1987) 0.98
Microheterogeneity of alpha 1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus. Arthritis Rheum (1987) 0.98
Determination of lectin-sugar dissociation constants by agarose affinity electrophoresis. Anal Biochem (1986) 0.96
[Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis]. Med Klin (Munich) (1993) 0.88
Still's disease in children and adults: a distinct pattern of acute-phase proteins. Clin Rheumatol (1998) 0.86
TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis. Rheumatol Int (2000) 0.86
Comparison of three immunoassays for C-reactive protein determination. Arch Immunol Ther Exp (Warsz) (1985) 0.84
Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone. Scand J Rheumatol Suppl (2004) 0.83
Glycosylation of alpha 1-acid glycoprotein in systemic onset juvenile rheumatoid arthritis and acute bacterial infection: value in differential diagnosis. J Rheumatol (1993) 0.82
The differences in the expression of CD45 isoforms on peripheral blood lymphocytes derived from patients with seasonal or perennial atopic allergy. Tohoku J Exp Med (1997) 0.80
Cytochemical studies of peripheral blood granulocytes and lymphocytes in patients with systemic lupus erythematosus. Pol Med Sci Hist Bull (1976) 0.80
Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis. J Rheumatol (1993) 0.79
Effect of thyroid hormone on the myosin heavy chain isoforms in slow and fast muscles of the rat. Acta Biochim Pol (1999) 0.78
[The heteroglycan profile of acute phase proteins in the differentiation of inflammatory processes]. Z Rheumatol (1990) 0.78
[An unusual case of Kartagener's syndrome associated with rheumatoid arthritis]. Pol Arch Med Wewn (1996) 0.78
Circulating interleukin 10 and interleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts: preliminary report. Inflamm Res (1995) 0.77
Studies on microheterogeneity of acute-phase proteins in rheumatoid arthritis by using crossed affinoimmuno-electrophoresis with free concanavalin A. Behring Inst Mitt (1986) 0.77
Microheterogeneity of alpha 1 acid glycoprotein in rheumatoid arthritis: dependent on disease duration? Ann Rheum Dis (1993) 0.77
Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins? Ups J Med Sci (1995) 0.77
Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart. J Physiol Pharmacol (1998) 0.77
Cytochemical studies of rosette-forming cells. Z Immunitatsforsch Exp Klin Immunol (1975) 0.76
Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis. Ann Med (1996) 0.76
The effect of methotrexate and azathioprine on the serum levels of IgA-alpha 1-antitrypsin complex in juvenile chronic arthritis. Braz J Med Biol Res (1997) 0.75
Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide. Z Rheumatol (1994) 0.75
[Use of indirect immunofluorescence in the determination of antiglobulin factors]. Pol Arch Med Wewn (1976) 0.75
HLA antigens and rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) (1977) 0.75
[Immunological basis of classification of lymphoproliferative diseases]. Pol Arch Med Wewn (1983) 0.75
[Muramidase activity in granulocytopenia]. Pol Arch Med Wewn (1970) 0.75
[Immunological mechanism in the pathogenesis of heart diseases]. Kardiol Pol (1977) 0.75
[Long term therapy of carditis. Report on 3 and one-half years of experience]. Z Arztl Fortbild (Jena) (1967) 0.75
[Immunological data in the clinical evaluation of Hodgkin's diseases]. Z Gesamte Inn Med (1981) 0.75
[Cytochemical studies of peripheral granulocytes and lymphocytes in patients wirh systemic lupus erythematous]. Pol Arch Med Wewn (1975) 0.75
C-reactive protein in management of children's burns. Ann Clin Res (1987) 0.75
[Morphological differentiation of peripheral blood lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus]. Pol Tyg Lek (1975) 0.75
[T-lymphoblastic crisis in myelocytic leukemia]. Pol Tyg Lek (1979) 0.75
[Mechanisms of autoimmunization]. Pol Arch Med Wewn (1985) 0.75
[Echocardiographic heart assessment in systemic lupus erythematosus]. Pol Merkur Lekarski (1997) 0.75
Subpopulations of blood lymphocytes in patients with rheumatoid arthritis. Z Immunitatsforsch Immunobiol (1976) 0.75
[Development of spontaneous and specific rosette formation in patients with rheumatoid arthritis]. Reumatologia (1975) 0.75
[Case of primary Hodgkin's disease of the small intestine]. Pol Tyg Lek (1982) 0.75
[Immunosuppressive treatment of chronic active hepatitis]. Pol Arch Med Wewn (1971) 0.75
[Bone tissue metabolism in systematic lupus erythematosus patients treated with glucocorticosteroids]. Pol Arch Med Wewn (2001) 0.75
[Cytochemical studies of peripheral leukocytes in rheumatoid arthritis]. Reumatologia (1973) 0.75
[Peripheral blood lymphocyte subpopulations in Hodgkin's disease]. Pol Tyg Lek (1975) 0.75
[Diagnostic criteria in systemic lupus erythematosus]. Pol Arch Med Wewn (1975) 0.75
[Clinical studies with strophanthidol-D-cymaroside (Cymarol)]. Dtsch Gesundheitsw (1970) 0.75
Activity of lysosomal enzymes and glycogen content of phytohemagglutinin-stimulated lymphocytes in patients with rheumatoid arthritis. Pol Med Sci Hist Bull (1976) 0.75
[Detection of rheumatoid factor by the rheumatoid rosette method]. Pol Arch Med Wewn (1976) 0.75
[Serum IgA, IgG and IgM in members of families of patients with rheumatoid arthritis]. Pol Arch Med Wewn (1974) 0.75
[Clinical immunology--a new branch of medicine]. Pol Tyg Lek (1975) 0.75
[Hairy cell leukemia - clinical and hematological features]. Pol Tyg Lek (1981) 0.75
[Nursing. Experienced staff ensures work quality 24-hours a day]. Sygeplejersken (1983) 0.75
Acute phase response in rheumatoid arthritis patients treated with immunosuppressive drugs. Mater Med Pol (1996) 0.75
Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard. Clin Rheumatol (1999) 0.75
[Surface markers of lymphocytes in lymphoproliferative diseases]. Pol Arch Med Wewn (1976) 0.75
[Autoradiographic studies of DNA synthesis in peripheral blood lymphocytes in patients with rheumatoid arthritis]. Pol Arch Med Wewn (1974) 0.75
Muramidase activity in granulocytopenia. Pol Med J (1971) 0.75
[Lymphocytes T, B and O in peripheral blood in human ontogenetic development]. Pol Tyg Lek (1977) 0.75
[Immunologic disorders syndromes associated with thymomas. Mechanisms of their pathogenesis]. Nowotwory (1975) 0.75
[Immunoglobulin receptors on the surface of peripheral blood lymphocytes in patients with rheumatoid arthritis]. Pol Arch Med Wewn (1975) 0.75
[Importance of enzymatic and cytochemical examinations in the diagnosis of acute myelogenic leukemia]. Acta Haematol Pol (1973) 0.75
[Cytology of the local immune response]. Reumatologia (1966) 0.75
[Immunologic aspects of non-Hodgkin's lymphoma]. Pol Arch Med Wewn (1978) 0.75
Occurrence of HLA antigens in patients with ankylosing spondylitis and in their families. Arch Immunol Ther Exp (Warsz) (1983) 0.75
Antiphospholipid antibodies and disturbances of phospholipid dependent coagulation tests in patients with systemic sclerosis and severe peripheral ischaemia. Thromb Res (1996) 0.75
[Report of the Committee on Establishing Criteria of Systemic Lupus Erythematosus]. Reumatologia (1975) 0.75
[Quantitative evaluation of the granulocyte system in viral hepatitis by way of determining plasma muramidase (lysozyme) activity]. Wiad Lek (1974) 0.75
[Muramidase (lysozyme) in differential diagnosis of acute leukemia]. Acta Haematol Pol (1974) 0.75
[Cellular immunity in Hodgkin's disease in complete remission]. Pol Tyg Lek (1980) 0.75
[Renal elimination of mucopeptide N-acetyl-muramyl-hydrolase (muramidase, lysozyme)]. Pol Arch Med Wewn (1972) 0.75
Effect of cyclophosphamide on the immune response to sheep erythrocytes in the mouse. II. A study of enzyme activities in the draining lymph node. Z Immunitatsforsch Exp Klin Immunol (1976) 0.75
[Activity of lysosomal enzymes and glycogen content in PHA-activated lymphocytes in patients with rheumatoid arthritis]. Pol Arch Med Wewn (1975) 0.75
[Severe autoimmune disease during atypical hyperplasia of immunologically competent cells]. Pol Arch Med Wewn (1965) 0.75
The coexistence of mutilating rheumatoid arthritis, progressive systemic sclerosis and polycythemia vera--a case report. Z Rheumatol (1993) 0.75
[Morphological and clinical variants of blastic crisis in chronic myeloid leukemia]. Pol Arch Med Wewn (1979) 0.75
[Effect of articular fluid on leukocyte migration inhibition in patients with rheumatoid arthritis]. Reumatologia (1975) 0.75
[Benign form of familial neutropenia with alkaline phosphatase deficiency in granulocytes]. Pol Arch Med Wewn (1972) 0.75
[Peripheral blood lymphocyte populations in viral hepatitis]. Pol Arch Med Wewn (1976) 0.75
Lectin inhibition system for determination of concanavalin A glycoprotein complexes dissociation constants in agarose affinity electrophoresis. Arch Immunol Ther Exp (Warsz) (1985) 0.75
A case of lymphoma with T-cell characteristics. Aust N Z J Med (1975) 0.75
[Evaluation of peripheral leukocyte migration inhibition test with aggregated human gamma globulin in patients with rheumatoid arthritis]. Pol Tyg Lek (1975) 0.75
[Lymphocyte subpopulations in the peripheral blood during polychemotherapy of non-Hodgkin's lymphoma]. Pol Tyg Lek (1985) 0.75
Effect of aggregated human gamma-globin on leukocyte migration-inhibitory test in patients with rheumatoid arthritis. Pol Med Sci Hist Bull (1977) 0.75
[Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV]. Pol Arch Med Wewn (1984) 0.75
[Usefulness of prednisone test in evaluation of bone marrow function]. Acta Haematol Pol (1973) 0.75
[Development of humoral immunity in the light of the studies of B-lymphocytes and serum immunoglobulins]. Pediatr Pol (1981) 0.75
[Pentaxins: their structure and function]. Postepy Hig Med Dosw (1988) 0.75
The effect of C-reactive protein on the PHA-induced proliferation of human peripheral blood lymphocytes. Arch Immunol Ther Exp (Warsz) (1985) 0.75
[Immunologic aspects of the effect of corticosteroids]. Pneumonol Pol (1976) 0.75
[Basophilic myeloid leukemia with changing morphological features]. Pol Tyg Lek (1975) 0.75
[Disorders of cellular immunity in Hodgkin's disease]. Pol Arch Med Wewn (1981) 0.75
[Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas]. Z Gesamte Inn Med (1981) 0.75
The presence of HLA-DR B1 shared motif does not influence cyclophosphamide and methotrexate cytotoxicity in rheumatoid arthritis patients. J Investig Allergol Clin Immunol (2001) 0.75
[Prognostic usefulness of clinical and laboratory indicators in patients with advanced forms of non-Hodgkin lymphoma treated by the COP protocol]. Pol Arch Med Wewn (1985) 0.75
[Repeated leukapheresis in a pregnant woman with myelocytic leukemia]. Pol Tyg Lek (1981) 0.75
[Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis]. Pol Arch Med Wewn (1975) 0.75